Physician

Darin R Haivala, M.D.

According to 2025 Medicare claims, Darin Haivala, M.D. (NPI: 1689641342) practices ophthalmology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is EYE ASSOCIATES OF OKLAHOMA PLLC (NPI: 1588685622; TIN: 20-4943767) and primary practice location at 73120-8604.

Haivala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 960 traditional Medicare patients, billed 26,094 HCPCS/CPT codes, and received $1,860,189 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 275 prescription claims across 92 beneficiaries totaling $21,500 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 2 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $697,996 to $1,860,189. In contrast, Part D prescription costs have declined steadily, from $36,434 to $21,500. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$930K$1.9M2015 Medicare payment: $697,996 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $912,945 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,018,088 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,181,084 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,359,839 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,341,040 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,372,713 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,198,011 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,521,438 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,860,189 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158486,659$697,996
20169138,155$912,945
20178738,136$1,018,088
20189078,672$1,181,084
20199229,075$1,359,839
20208637,394$1,341,040
20218937,601$1,372,713
20229059,022$1,198,011
202393518,817$1,521,438
202496026,094$1,860,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$36K2015 Drug cost: $36,434 (USD; Tot_Drug_Cst)2016 Drug cost: $27,316 (USD; Tot_Drug_Cst)2017 Drug cost: $31,415 (USD; Tot_Drug_Cst)2018 Drug cost: $18,336 (USD; Tot_Drug_Cst)2019 Drug cost: $26,198 (USD; Tot_Drug_Cst)2020 Drug cost: $28,482 (USD; Tot_Drug_Cst)2021 Drug cost: $19,729 (USD; Tot_Drug_Cst)2022 Drug cost: $16,861 (USD; Tot_Drug_Cst)2023 Drug cost: $20,603 (USD; Tot_Drug_Cst)2024 Drug cost: $21,500 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201595321$36,434
201683268$27,316
201789268$31,415
201877222$18,336
201991313$26,198
2020100277$28,482
202194237$19,729
202275221$16,861
202393270$20,603
202492275$21,500

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3101,353$87
92014Established patient complete exam of visual system391408$83
92012Established patient problem focused exam of visual system453907$61
92250Photography of the retina429570$26
92134Imaging of retina6161,907$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost18624$5,507
Prednisolone AcetatePrednisolone Acetate781,643$2,248
MoxifloxacinMoxifloxacin Hcl27293$619
OfloxacinOfloxacin24335$226
LatanoprostLatanoprost291,153$122

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$88Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Darin R. Haivala, M.D.?

Tedicare shows public-source Medicare data for Darin R. Haivala, M.D. (NPI 1689641342), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Darin R. Haivala, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Darin R. Haivala, M.D.?

Darin R. Haivala, M.D. is linked to EYE ASSOCIATES OF OKLAHOMA PLLC (billing NPI 1588685622) in the available physician profile data.

Does Darin R. Haivala, M.D. have Open Payments data?

Darin R. Haivala, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.